21st Century Oncology Physician to present research at Radiosurgery Society Meeting

Dr. Constantine Mantz, chief medical officer of 21st Century Oncology, will present his research on the use of stereotactic body radiothera

21st Century Oncology
Physician to present research at Radiosurgery Society Meeting

 

(Fort Myers, Fla. – February 29, 2012 ) – Dr. Constantine Mantz, chief medical
officer of 21st Century Oncology, will present his research on the
use of stereotactic body radiotherapy (SBRT)in the treatment of prostate
cancer, at the Annual The Radiosurgery Society™
(RSS) Meeting in Carlsbad California last week (Feb. 22-25). This is one
of the largest and most prestigious gatherings of medical professionals engaged
in the use of Radiosurgery in the treatment of cancer. Dr. Mantz is one of a
very few community-based physicians presenting research at this leading
gathering of medical professionals.

SBRT differs from traditional radiotherapy
for prostate cancer in that higher doses are administered over a shorter number
of treatments.  Using SBRT along with the Calypso System, a device which
enables physicians to deliver an increased dose of radiation directly to the
tumor while helping to spare the surrounding organs, allows men to effectively
combat prostate cancer and for many patients, it can serve as a viable
alternative to invasive surgery. 

According to Dr. Mantz,  SBRT is showing
promising results.  “Results from this research study show that real-time
tumor tracking with SBRT for early stage prostate cancer has clinically
significant benefits in improving the quality of life after diagnosis and
treatment,” said Dr. Mantz.

“Prostate cancer is, unfortunately, very
prevalent in our society. That is why continued research is so important,” Dr.
Mantz says. “It’s an honor to present this research to a group of peers and to
be able to inform the medical community about these advancements in treatment.”

Formerly The CyberKnife® Society™ (CKS), the
newly-named Radiosurgery Society has been expanded to serve as a forum for
discourse within the entire radiosurgery community, including radiation
oncologists, radiation physicists, surgeons, and radiation therapists. The
Society is not sponsored by any pharmaceutical company or equipment
manufacturer, allowing  it to represent the entire community of medical
professionals engaged in advancing the science of focused irradiation using the
full spectrum of delivery mechanisms, free of any commercial bias or specific
association. In keeping with its mission, the Society will conduct an open
academic meeting planned by medical professionals for medical professionals.

About 21st Century Oncology

Headquartered in Fort Myers, 21st
Century Oncology, Inc. is a leading developer and operator of radiation therapy
centers in the U.S. For 30 years, 21st Century Oncology has been committed to
providing premier, quality, cost-effective radiation therapy services that are
responsive to the needs of its patients through continuous improvement and
innovation. The company operates in 16 states and has more than 20 offices in
Southwest Florida.